Concepedia

Therese Callaghan

TC

Statistics

Publications

4

Citations

71

H-Index

4

Active since

1991

Affiliations

University of Liverpool(Current)

Therese Callaghan is an author at University of Liverpool specializing in medicine, hematology, and cancer immunology.

Publications per year

1991–2014

4

Publications

4

Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients

Richard E. Clark, Jo Bell, Jack O. Clark et al. · Blood Cancer Journal · 2014 · 32 citations · Full text

, , +17

Continuous intravenous infusion of high dose recombinant interleukin 2 for advanced lymphomas—A phase II study

Seah H. Lim, C. P. Worman, Therese Callaghan et al. · Leukemia Research · 1991 · 15 citations

, , +11

Comparison of <i>in vivo</i> red cell survival of donations collected by Haemonetics MCS versus conventional collection

Fiona Regan, P. Teesdale, Stephen F. Garner et al. · Transfusion Medicine · 1997 · 12 citations

, , +15

BCR-ABL peptide vaccination in healthy subjects: Immunological responses are equivalent to those in chronic myeloid leukaemia patients

José M. Rojas, Katy Knight, Sarah Watmough et al. · Leukemia Research · 2010 · 12 citations

, , +16

1–4 of 4